[Oncoinfo – Istantanee di Oncologia: seguici su [ Ссылка ]] In this time of melanoma history neoadjuvant immunotherapy is rapidly becoming a standard treatment. But what wll we see in the next future? We asked Georgina Long (Co-Medical Director of Melanoma Institute Australia - MIA, Chair of Melanoma Medical Oncology and Translational Research at MIA and Royal North Shore Hospital, The University of Sydney) that we met at Melanoma Bridge congress 2023 in Naples.

свернуть